Anchor My Faith

Learn more

Section 7.1 Laboratory

Laboratory Report #7

Date

Collection Date: August 2, 2019
Report Date: August 3, 2019

Laboratory

Labcorp

Ordering Physician

Dr. Billy R. Boring, Jr.

Report Type

Comprehensive Annual Health Evaluation

Laboratory testing included:

  • Complete Blood Count (CBC) with Differential
  • Comprehensive Metabolic Panel
  • Lipid Panel
  • Hemoglobin A1c
  • Free T4
  • TSH
  • Prostate-Specific Antigen (PSA)
  • Routine Urinalysis

Original Report

PDF: Labcorp – August 2, 2019

One-Page Summary

Purpose of Testing

This annual laboratory evaluation documents overall health at age 82 and represents the final comprehensive baseline assessment before the health changes that began during 2020–2021. The report demonstrates continued stability in kidney, liver, metabolic, and thyroid function while identifying continued mild anemia, a rise in cholesterol levels, and the first PSA result above the laboratory reference range. As such, it serves as an important transition point in the Health Inventory.

Major Findings

Metabolic Health

Results

  • Glucose: 83 mg/dL
  • Hemoglobin A1c: 5.5%

Interpretation

Glucose regulation remained excellent. Hemoglobin A1c continued within the normal reference range, indicating stable long-term glucose control without evidence of diabetes or prediabetes.

Kidney Function

Results

  • BUN: 20 mg/dL
  • Creatinine: 0.97 mg/dL
  • eGFR: 72 mL/min/1.73 m²

Interpretation

Kidney function remained stable and appropriate for age. There was no laboratory evidence of progressive renal disease.

Liver Function

Results

  • AST: 23 IU/L
  • ALT: 14 IU/L
  • Alkaline Phosphatase: 59 IU/L
  • Bilirubin: 0.3 mg/dL

Interpretation

Liver function tests remained entirely within normal limits, demonstrating continued healthy hepatic function.

Complete Blood Count

Results

  • WBC: 4.9 ×10³/µL
  • Hemoglobin: 12.8 g/dL (slightly below reference range)
  • Hematocrit: 39.8%
  • Platelets: 249 ×10³/µL

Interpretation

The complete blood count remained stable. Mildly reduced hemoglobin persisted without progression, while white blood cell and platelet counts remained normal. This continued the mild hematologic pattern documented since 2017 and provided an important baseline before the more significant anemia that developed during the inflammatory illness in 2021.

Lipid Profile

Results

  • Total Cholesterol: 208 mg/dL
  • LDL Cholesterol: 126 mg/dL
  • HDL Cholesterol: 71 mg/dL
  • Triglycerides: 57 mg/dL

Interpretation

The lipid profile continued to demonstrate a favorable metabolic pattern despite higher cholesterol values.

Notable features included:

  • High HDL cholesterol.
  • Very low triglycerides.
  • Increase in total cholesterol and LDL cholesterol compared with 2018.

Although LDL cholesterol increased, the overall pattern of high HDL and low triglycerides remained consistent with previous years.

Thyroid Function

Results

  • TSH: 2.810 μIU/mL
  • Free T4: 1.13 ng/dL

Interpretation

Thyroid function remained stable with both TSH and Free T4 within their normal reference ranges.

Prostate Screening

Result

  • PSA: 4.4 ng/mL (above laboratory reference range)

Interpretation

This is the first PSA result in the available laboratory history to exceed the laboratory reference range. While a single elevated PSA does not establish a diagnosis, it represents an important change that warranted continued monitoring and clinical correlation.

Urinalysis

Routine urinalysis was essentially normal.

Findings included:

  • No protein
  • No glucose
  • No blood
  • No infection

The only abnormality was a urine pH of 8.0, slightly above the laboratory reference range. As in previous years, this isolated finding was not accompanied by any other urinary abnormalities.

Overall Interpretation

This report documents excellent overall health at age 82. Kidney function, liver function, glucose metabolism, thyroid function, and urinalysis remained stable. The lipid profile continued to demonstrate the characteristic pattern of high HDL cholesterol and very low triglycerides despite an increase in LDL cholesterol. Mild anemia remained unchanged. The most notable new finding was the first PSA value above the laboratory reference range, establishing a new trend for future monitoring. Overall, this report represents the final comprehensive laboratory baseline before the significant inflammatory illness that developed in 2021.

Longitudinal Significance

This report contributed to long-term trend analysis of:

  • Blood counts
  • Kidney function
  • Liver function
  • Lipid profile
  • Glucose metabolism
  • Thyroid function
  • PSA
  • Urinalysis

It serves as the final stable annual laboratory assessment before the major health transition beginning in 2021.

Clinical Importance

⭐⭐⭐ Final Pre-Inflammatory Baseline

This report marks the end of a prolonged period of laboratory stability. It establishes the reference point against which the dramatic inflammatory and hematologic changes of 2021 can be measured.

Key Changes Since Previous Report

  • Hemoglobin remained stable at 12.8 g/dL.
  • Total cholesterol increased from 185 to 208 mg/dL.
  • LDL cholesterol increased from 101 to 126 mg/dL.
  • HDL cholesterol remained high (73 → 71 mg/dL).
  • Triglycerides remained very low (55 → 57 mg/dL).
  • Hemoglobin A1c remained normal (5.3% → 5.5%).
  • Kidney, liver, thyroid, and glucose regulation remained stable.
  • PSA increased from 3.4 to 4.4 ng/mL, becoming the first result above the laboratory reference range.

Related Reports

  • Blood Trend Tables
  • Kidney Function Trend Tables
  • Liver Function Trend Tables
  • Lipid Trend Tables
  • Glucose Trend Tables
  • Thyroid Trend Tables
  • Prostate Health Trend Tables
  • Medical History Timeline

Navigation

  • Previous Report: July 30, 2018 – Labcorp Comprehensive Annual Health Evaluation
  • Next Report: February 4, 2021 – Laboratory Evaluation During Early Inflammatory Illness
  • Return to Laboratory Library
  • Return to Health Inventory

Observation

Looking back over the 2013–2019 reports as a group, they tell a remarkably consistent story. For seven consecutive years:

  • Kidney function remained stable.
  • Liver function remained normal.
  • Blood glucose control remained excellent.
  • Thyroid function remained well controlled.
  • The lipid profile consistently showed high HDL cholesterol and very low triglycerides, despite fluctuations in LDL cholesterol.
  • Mild anemia was present but stable from 2017 onward.

This 2019 report is particularly significant because it serves as the last documented laboratory snapshot before your health entered a markedly different phase. When compared with the reports from 2021, it clearly demonstrates how abruptly the systemic inflammatory illness altered laboratory patterns that had been stable for many years.